Alopecia Areata Treatment Market Size, Epidemiology, Drugs Pipeline, Market Analysis and Companies by DelveInsight

Alopecia Areata (AA), an autoimmune skin disorder, in which the hair follicles get damaged by a faulty immune system. This faultiness causes the immune system to attack its own body, thus disrupting hair follicles and new hair formation. Biopsies performed have clearly shown the immune lymphocytes travelling in the hair bulbs of the hair follicle. The condition can lead to extreme hair loss in aggravated stages from the entire body, known as Alopecia universalis or it can lead to overall loss of hair from the scalp area, also called Alopecia Totalis.

DelveInsight's "Alopecia Areata Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Alopecia Areata, historical and forecasted epidemiology as well as the Alopecia Areata market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Alopecia Areata Symptoms

·         Patchy hair loss

·         Inflammation of the hair follicles

·         Cadaver hairs

·         White spots and lines appear

·         Pinpoint dents appear

Request for Free Sample Report: https://www.delveinsight.com/sample-request/alopecia-areata-market

View Report: https://www.delveinsight.com/report-store/alopecia-areata-market

Some facts of Alopecia Areata Market Report:

·         According to the Chantal Bolduc et al., 2018, the prevalence of alopecia areata (AA) in the general population is estimated to be 0.1–0.2%. The lifetime risk of developing alopecia areata is estimated to be 1.7%. All races are affected equally by alopecia areata and no increase in prevalence has been found in a particular ethnic group.

·         As per the study conducted by Alexandra C. Villasante Fricke et al. in 2015, the scalp is the most common site of involvement, with or without involvement of other body sites (such as the eyebrows, eyelashes, and beard). Specifically, the most common site was the occipital region, involved in 38.4% of males and 33.4% of females. Upon first presentation, 58% of adult patients had patchy hair loss with less than half the scalp involved. On the other hand, in children, 80–85% had mild-to-moderate hair loss involving less than half the scalp.

·         As per the National Organization of Rare Disease, alopecia areata is most common among the children and approximately 2.5 million people are suffering from alopecia areata in the United States.

·         As per Herbert Pratt et al. 2017, alopecia areata affects approximately two percent of the general population at some point during their lifetime

·         According to the National Alopecia Areata Foundation, approximately 6.8 million people in the United States and 147 million worldwide have or will develop alopecia areata at some point in their lives.

·         As per Alexandra C Villasante Fricke et al., 2015, patients with AA experience their first onset of AA by age 40 years in 82.6–88% of patients and by age 20 years in 40.2% of patients. The mean age of onset has been reported as between 25.2 and 36.3 years. In children, the mean age of onset has been reported as between ages 5 and 10 years.

Download Free Sample Report: https://www.delveinsight.com/sample-request/alopecia-areata-market

View Report: https://www.delveinsight.com/report-store/alopecia-areata-market

Alopecia Areata Treatment Market

The treatments commonly prescribed to AA patients include Injections, Oral, Topical Treatments and Light therapy.

Alopecia Areata Injections:

Steroid injections are commonly used in the treatment of AA, mainly for bald and patchy areas on the scalp. Steroidal injections are injected on the bare part of the affected area. Although it does not stop the hair fall, but effectively helps in regeneration of hair. The treatment is to be repeated in every one to two months.

Alopecia Areata Oral Treatments:

Cortisone tablets are majorly recommended for severe forms of AA. However, cortisone causes major side effects as well. Immunosuppressants such as methotrexate and cyclosporine are also recommended. They work by creating an obstruction for the immune system, but they cannot be ingested for prolonged periods due to serious side effects such as lymphoma, kidney and liver damages etc.

Alopecia Areata Topical Treatments:

Many types of topical treatments are rubbed on the scalp area and other regions of the body including eyebrows and beard. These involve Minoxidil (Rogaine), Anthralin (Dritho-Scalp), clobetasol (Impoyz), Diphencyprone etc.

Alopecia Areata Light Therapy:

This form of therapy uses a combination of psoralens and Ultra-violet light to treat AA.

View Report: https://www.delveinsight.com/report-store/alopecia-areata-market

Request for Free Sample Report: https://www.delveinsight.com/sample-request/alopecia-areata-market

Some of Alopecia Areata Companies are:

·         Pfizer

·         Suzhou Zelgen Biopharmaceuticals

·         Eli Lilly and Company

·         Incyte Corporation

·         Aclaris Therapeutics

·         Legacy Healthcare

·         Concert Pharmaceuticals

·          LEO Pharma

·         Bristol-Myers Squibb

·         And Many Others

Alopecia Areata Therapies are:

·         PF-06651600

·         Jaktinib

·         Baricitinib

·         ATI-502

·         Abatacept

·         LH-8

·         LEO 124249

·         CTP-543

·         And Many Others

View Report: https://www.delveinsight.com/report-store/alopecia-areata-market

Request for Free Sample Report: https://www.delveinsight.com/sample-request/alopecia-areata-market

Table of Contents:

1. Key Insights

2. Executive Summary of Alopecia Areata

3. Competitive Intelligence Analysis for Alopecia Areata

4. Alopecia Areata: Market Overview at a Glance

4.1. Alopecia Areata Total Market Share (%) Distribution in 2018

4.2. Alopecia Areata Total Market Share (%) Distribution in 2030

5. Alopecia Areata: Disease Background and Overview

6. Patient Journey

7. Alopecia Areata Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Alopecia Areata Treatment

11. Marketed Products

List to be continued in report

12. Emerging Therapies

List to be continued in report

13. Alopecia Areata: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Alopecia Areata

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

Related Reports:

·         Ventilator Market

·         Apraxia Market

·         Autonomic Dysfunction Market

·         Allergic Rhinoconjunctivitis Market

·         Breast Pumps Market

·         Biochips Market

·         Artificial Iris Market

·         Urolithiasis Market

·         Acute Coronary Syndrome Market

·         Brain Aneurysm Stents Market

·         Pediatric Growth Hormone Deficiency Pghd Market

·         Eczema Market

·         Rituximab Biosimilars Insight

·         Bone Grafts And Substitutes Market

·         Bile Duct Neoplasm Market

·         Emesis Market

·         Pulmonary Hypertension Associated With Interstitial Lung Disease Market

·         Ranibizumab Biosimilar Insight

·         Adrenocortical Carcinoma Market

·         Advanced Hepatocellular Carcinoma with CPB Liver Cirrhosis Market

·         Advanced Recurrent Ovarian Cancer Market

·         Age-Related Macular Degeneration Market

·         Alopecia Aerata Market

·         Anal Cancer Market

·         Anaphylaxis Market

·         Angioedema Market

·         Anti-GBM disease Market

·         Antiphospholipid Syndrome (APS) Market

·         Interbody Cages Market

·         Osteoarthritis Market

About Delveinsight: 

DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

Know More about our competitive intelligence services.

Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.

Media Contact

 Company Name: DelveInsight Business Research LLP

 Contact Person: Ankit Nigam

 Email: info@delveinsight.com

 Phone: +19193216187

 City: Albany

 State: New York

 Country: United States

 Website: https://www.delveinsight.com/